Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-Week analysis

Anthony M. Mills, Mark Nelson, Dushyantha Jayaweera, Kiat Ruxrungtham, Isabel Cassetti, Pierre Marie Girard, Cassy Workman, Inge Dierynck, Vanitha Sekar, Carline Vanden Abeele, Ludo Lavreys

Research output: Contribution to journalArticlepeer-review

236 Scopus citations

Fingerprint

Dive into the research topics of 'Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-Week analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences